Literature DB >> 3012807

Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion.

A D Lakeman, A J Nahmias, R J Whitley.   

Abstract

In a blind study, DNA from 40 clinical isolates of herpes simplex viruses was analyzed by restriction endonucleases to determine whether serial isolates from an individual patient could be identified and whether exogenous reinfection occurred within this population. Five of the 40 isolates served as controls. Based on restriction patterns obtained following Bam H1 cleavage of DNA, 35 isolates were assigned to 15 patients. Isolates from two patients displayed variation in the electrophoretic mobility of certain Bam H1 fragments. However, the isolates from one patient were identical when digested with four additional enzymes. One of three sequential isolates from a patient, when cleaved with Eco R1 and Hind III, showed variable fragments in the terminal and joint regions of the S segment of the genome. The appearance of the fragments was not due to the addition of a known restriction site. We conclude that exogenous reinfection with a genetically distinct strain of herpes simplex virus type 2 (HSV-2) did not occur among these 15 patients with recurrent genital HSV infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012807     DOI: 10.1097/00007435-198604000-00001

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.

Authors:  Christine Johnston; Amalia Magaret; Pavitra Roychoudhury; Alexander L Greninger; Anqi Cheng; Kurt Diem; Matthew P Fitzgibbon; Meei-Li Huang; Stacy Selke; Jairam R Lingappa; Connie Celum; Keith R Jerome; Anna Wald; David M Koelle
Journal:  Virology       Date:  2017-07-13       Impact factor: 3.616

Review 2.  HSV-2: in pursuit of a vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 3.  Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.

Authors:  Chris L McGowin; Richard B Pyles
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

4.  Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice.

Authors:  Natalie V Akhrameyeva; Pengwei Zhang; Nao Sugiyama; Samuel M Behar; Feng Yao
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

5.  Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.

Authors:  Richard Brans; Feng Yao
Journal:  BMC Microbiol       Date:  2010-06-03       Impact factor: 3.605

Review 6.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

7.  Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2011-06-24       Impact factor: 2.432

8.  Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.

Authors:  Christine Johnston; Amalia Magaret; Pavitra Roychoudhury; Alexander L Greninger; Daniel Reeves; Joshua Schiffer; Keith R Jerome; Cassandra Sather; Kurt Diem; Jairam R Lingappa; Connie Celum; David M Koelle; Anna Wald
Journal:  PLoS Med       Date:  2017-12-27       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.